Endothelial function in Marfan syndrome: Selective impairment of flow- mediated vasodilation

Circulation

Volumn 99, Issue 7, 1999, Pages 909-915

  Wilson, Dirk G ^a   Bellamy, Michael F ^b   Ramsey, Mark W ^b   Goodfellow, Jonathan ^b   Brownlee, Moira ^b   Davies, Sally ^a   Wilson, John F ^b   Lewis, Malcolm J ^b   Stuart, A Graham ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Arteries; Endothelium; Endothelium derived factors; Marfan syndrome

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MARFAN SYNDROME; PRIORITY JOURNAL; SCHOOL CHILD; TUNICA MEDIA; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0033596639     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.7.909     Document Type: Article

References (48)

1. Kainulainen K, Pulkkinen L, Savolainen A, Kaitila I, Peltonen L. Location on chromosome 15 of the gene defect causing Marfan syndrome. N Engl J Med. 1990;323:935-939.
2. Pyeritz RE. The Marfan syndrome. In: Royce PM. Steinman B, eds. Connective Tissue and Its Heritable Disorders. New York, NY: Wiley-Liss; 1993:437-468.
3. Meecham RP, Heuser JE. The elastic fiber. In: Hay ED, ed. Cell Biology of Extracellular Matrix. 2nd ed. New York, NY: Plenum Press; 1991: 79-109.
4. Kielty CM, Shuttleworth CA. Fibrillin-containing microfibrils: structure and function in health and disease. Int J Biochem Cell Biol. 1995;27: 747-760.
5. Kumaratilake JS, Gibson MA, Fanning JC, Cleary EG. The tissue distribution of microfibrils reacting with a monospecific antibody to MAGP, the major glycoprotein antigen of elastin-associated microfibrils. Eur J Cell Biol. 1989;50:117-127.
6. Malak TM, Bell SC. Distribution of fibrillin-containing microfibrils and elastin in human fetal membranes: a novel molecular basis for membrane elasticity. Am J Obstet Gynecol. 1994;171:196-205.
7. Perejda AJ, Abraham PA, Carnes WH, Coulson WF, Uitto J. Marfan's syndrome: structural, biochemical, and mechanical studies of the aortic media. J Lab Clin Med. 1985;106:376-383.
8. Hirata K, Triposkiadis F, Sparks E, Bowen J, Wooley CF, Boudoulas H. The Marfan syndrome: abnormal aortic elastic properties. J Am Coll Cardiol. 1991;18:57-63.
9. Haust MD, More RH, Benscombe SA, Baus JU. Elastogenesis in human aorta: an electron microscopic study. Exp Mol Pathol. 1965;4:508-524.
10. Cleary RG, Gibson MA. Elastin-associated microfibrils and microfibrillar proteins. Int Rev Connect Tissue Res. 1983;10:97-209. Review.
11. Kielty CM, Wilson DG, Stuart G, Musumeci F, Jones CJ, Davies S, Shuttleworth A. Fibrillin expression and deposition by vascular endothelial cells: implications for the Marfan syndrome. Circulation. 1996; 94(suppl I):I-350. Abstract.
12. Moncada S, Palmer RMJ. Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-142.
13. Förstermann U, Nakane M, Tracey WR, Pollock JS, Isoforms of nitric oxide synthase: functions in the cardiovascular system. Eur Heart J. 1993;14(suppl I): 10-15.
14. Furchgott RF. The role of endothelium in the responses of vascular smooth muscle to drugs. Ann Rev Pharmacol Toxicol. 1984;24:175-197.
15. Cocks TM, Angus JA, Campbell JH, Campbell GR. Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture. J Cell Physiol. 1985;123:310-320.
16. Newby AC, Henderson AH. Stimulus-secretion coupling in vascular endothelial cells. Ann Rev Physiol. 1990;52:661-674.
17. Pohl U, Holtz J, Busse R, Bassenge E. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension. 1986;8: 37-47.
18. Busse R, Pohl U. Fluid shear-stress-dependent stimulation of endothelial cell autacoid release: mechanisms and significance for the control of vascular tone. In: Frangos JA, Ives CL, eds. Physical Forces and the Mammalian Cell. Orlando. Fla: Academic Press; 1993:223-248.
19. Meredith IT, Currie KE, Anderson TJ, Roddy M-A, Ganz P, Creager MA. Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol. 1996;270:H1435-H1440.
20. Ramsey MW, Goodfellow J, Jones CHJ, Luddington LA, Lewis MJ, Henderson AH. Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation. 1995;92:3212-3219.
21. Brigdes AB, Gray JR, McLaren M, Tamei H, Belch JJF. Endothelial cell and platelet function in Marfan syndrome. Endothelium. 1993;1:203-206.
22. De Paepe A, Devereux RB, Dietz HC, Hennekam RCM, Pyeritz RE. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet. 1996;62:417-426.
23. Roman MJ, Devereux RB, Kramer-Fox R, O'Loughlin J. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol. 1989;64:507-512.
24. de Man SA, André J-L, Bachmann H, Grobbee DE, Ibsen KK, Laaser U, Lippert P, Hofman A. Blood pressure in childhood: pooled findings of six European studies. J Hypertens. 1991;9:109-114.
25. Ubbink JB, Vermaak WJH, Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr. 1991;565:441-446.
26. Kuo AK, Still R, Cale S, McDowell IFN. HPLC assay for plasma homocysteine utilising cysteamine as internal standard. J Inherit Metab Dis. 1996;19(suppl 1):28. Abstract.
27. Shores J, Berger KR, Murphy EA, Pyeritz RE. Progression of aortic dilatation and the benefit of long-term β-adrenergic blockade in Marfan's syndrome. N Engl J Med. 1994;330:1335-1341.
28. Boucek RJ, Gunja-Smith Z, Noble NL, Simpson CF. Modulation by propranolol of the lysyl cross-links in aortic elastin and collagen of the aneurysm-prone turkey. Biochem Pharmacol. 1983;32:275-280.
29. Yin FCP, Brin KP, Ting C-T, Pyeritz RE. Arterial hemodynamic indexes in Marfan's syndrome. Circulation. 1989;79:854-862.
30. Chowienezyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet. 1992;340:1430-1432.
31. Panza J, Quyyumi AA, Brush JJ, Epstein S. Abnormal endothelial-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
32. Goodfellow J, Ramsey MW, Luddington LA, Jones CJH, Coates PA, Dunstan F, Lewis MJ, Owens DR, Henderson AH. Endothelium and inelastic arteries: an early marker of vascular dysfunction in non-insulin dependent diabetes. BMJ. 1996;312:744-745.
33. Bellamy MF, Ramsey MW, Goodfellow J, Brownlee M, Gorman S, McDowell IF, Lewis MJ. Hyperhomocysteinemia and endothelial dysfunction with low vitamin B12/folate status. Circulation. 1996;94(suppl I):I-462. Abstract.
34. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation. 1997;95:1119-1121.
35. Celermajer DS, Sorensen KE, Gooch VM, Speigelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
36. Celermajer DS, Adams MR, Clarkson P, Robinson J, McCredie R, Donald A, Deanfield JE. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med. 1996;334:150-154.
37. Zeiher AM, Drexler H, Wollschläger H, Just H. Modulation of coronary vasomotor tone in adults: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83:391-401.
38. Anderson TJ, Gerhard MD, Meredith IT, Charbonneau F, Delagrange D, Craeger MA, Selwyn AP, Ganz P. Systemic nature of endothelial dysfunction in atherosclerosis. Am J Cardiol. 1995;75:71B-74B.
39. Hutcheson IR, Smith JA, Griffith TM. Abolition of flow-dependent EDRF release before that evoked by agonists in hypercholesterolaemic rabbits. Br J Phamacol. 1994;113:190-194.
40. Busse R, Fleming I, Hecker M. Signal transduction in endothelium-dependent vasodilatation. Eur Heart J. 1993;14(suppl I):2-9.
41. Pohl U, Merlan K, Huang A, Bassenge E. EDRF-mediated shear-induced dilation opposes myogenic vasoconstriction in small rabbit arteries. Am J Physiol. 1991;261:H2016-H2023.
42. Davies PF, Tripathi SC. Mechanical stress mechanisms and the cell. Circ Res. 1993;72:239-245.
43. Wang N, Butler JP, Ingeber DE. Mechanotransduction across the cell surface and through the cytoskeleton. Science. 1993;260:1124-1127.
44. Burridge K, Fath K, Kelly T, Nuckolls G, Turner C. Transmembrane junctions between the extracellular matrix and the cytoskeleton. Ann Rev Cell Biol. 1988;4:487-525.
45. Albelda SM, Buck CA. Integrins and other cell adhesion molecules. FASEB J. 1990;4:2868-2880.
46. Ingeber D. Integrins as mechanical transducers. Curr Opin Cell Biol. 1991;3:841-848.
47. Ingeber D, Karp S, Plopper G, Hansen L, Mooney D. Mechanical transduction across extracellular matrix and through the cytoskeleton. In: Frangos JA, Ives CL, eds. Physical Forces and the Mammalian Cell. Orlando, Fla: Academic Press; 1993:61-79.
48. Hutcheson IR, Griffith TM. Mechanotransduction through the cytoskeleton: mediation of flow-but not agonist-induced EDRF release. Br J Pharmacol. 1996;118:720-726.